Evidence map›Paper›PMID 20091870›Full record

ReviewBiopolymers2010

Fibrillar peptide gels in biotechnology and biomedicine.

Jangwook P Jung, Joshua Z Gasiorowski, Joel H Collier

Abstract readReview
In one paragraph

Review in Biopolymers, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Peptide Tectonics: Encoded Structural Complementarity Dictates Programmable Self-Assembly.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Self-assembly and gelation properties of glycine/leucine Fmoc-dipeptides.The European physical journal. E, Soft matter · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jangwook P JungDepartment of Surgery and Committee on Molecular Medicine, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.
Joshua Z Gasiorowski
Joel H Collier

Funding

Modular Self-Assembled Coatings for BiomaterialsR01EB009701 · NIBIB · UNIVERSITY OF CHICAGO · PI COLLIER, JOEL H · 2009 to 2021
$4.3M
Designing ECM-Inspired Peptide Biomaterials for Regenerative MedicineR21DE017703 · NIDCR · UNIVERSITY OF CINCINNATI · PI COLLIER, JOEL H · 2006 to 2007
$422k
Modular Biomaterials for Cell Sheet RegenerationR21EB007335 · NIBIB · UNIVERSITY OF CINCINNATI · PI COLLIER, JOEL H · 2007 to 2008
$421k
NIBIB NIH HHS EB007335NIBIB NIH HHS R01 EB009701NIBIB NIH HHS R21 EB007335NIDCR NIH HHS DE017703
6 · The paper itself

Abstract

Peptides, peptidomimetics, and peptide derivatives that self-assemble into fibrillar gels have received increasing interest as synthetic extracellular matrices for applications in 3D cell culture and regenerative medicine. Recently, several of these fibrillizing molecules have been functionalized with bioactive components and chemical features such as cell-binding ligands, degradable sequences, drug eluting compounds, and cross-linkable groups, thereby producing gels that can reliably display multiple factors simultaneously. This capacity for incorporating precise levels of many different biological and chemical factors is advantageous given the natural complexity of cell-matrix interactions that many current biomaterial strategies seek to mimic. In this review, recent efforts in the area of fibril-forming peptide materials are described, and advantages of biomaterials containing multiple modular elements are outlined. In addition, a few hurdles and open questions surrounding fibrillar peptide gels are discussed, including issues of the materials' structural heterogeneity, challenges in fully characterizing the diversity of their self-assembled structures, and incomplete knowledge of how the materials are processed in vivo.

Indexed as

Biomedical EngineeringBiotechnologyProtein ConformationBiocompatible MaterialsExtracellular MatrixGelsHumansMolecular StructurePeptidesProteinsBiocompatible MaterialsGelsPeptidesProteins

Identifiers

PMID20091870
PMCPMC3380801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.